FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia Genetic Test
Welcome to DNA Labs UAE, where we offer the FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia Genetic Test. This test is designed to provide valuable insights into the genetic factors associated with craniofacial-skeletal-dermatologic dysplasia, a rare genetic disorder.
Test Details
The FGFR2 gene plays a crucial role in the development and maintenance of various tissues in the body, including the craniofacial, skeletal, and dermatologic tissues. Craniofacial-skeletal-dermatologic dysplasia is a genetic disorder caused by mutations in the FGFR2 gene. It affects the development of craniofacial bones, leading to abnormalities such as a prominent forehead, wide-set eyes, and a beaked nose. It also affects skeletal and dermatologic tissues, resulting in abnormal bone growth, fusion, and thickened, scaly skin.
Test Components and Price
The FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
After the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology, allowing for the simultaneous analysis of multiple genes or even the entire genome.
Test Type and Doctor
The FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia Genetic Test falls under the categories of osteology, dermatology, and immunology disorders. It is recommended to consult with a dermatologist for this test.
Pre Test Information
Prior to undergoing the FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia.
Conclusion
The FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia Genetic Test offered by DNA Labs UAE is a valuable tool for diagnosing this rare genetic disorder. NGS genetic testing allows for the identification of mutations in the FGFR2 gene, providing important information about the condition’s severity and guiding treatment options. If you suspect craniofacial-skeletal-dermatologic dysplasia, consult with a dermatologist and consider undergoing this genetic test for a comprehensive evaluation.
Test Name | FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR2 Gene Craniofacial-skeletal-dermatologic dysplasia NGS Genetic DNA Test gene FGFR2 |
Test Details |
The FGFR2 gene is a gene that provides instructions for making a protein called fibroblast growth factor receptor 2. This protein is involved in the development and maintenance of various tissues in the body, including the craniofacial (head and face), skeletal (bones), and dermatologic (skin) tissues. Craniofacial-skeletal-dermatologic dysplasia is a rare genetic disorder that is caused by mutations in the FGFR2 gene. This condition affects the development of the craniofacial bones and leads to various craniofacial abnormalities, such as a prominent forehead, wide-set eyes, and a beaked nose. It can also cause skeletal abnormalities, including abnormal bone growth and fusion, as well as dermatologic abnormalities, such as thickened and scaly skin. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of FGFR2 gene craniofacial-skeletal-dermatologic dysplasia, NGS genetic testing can be used to identify mutations or changes in the FGFR2 gene that are responsible for the disorder. This can help with the diagnosis of the condition and may also provide information about the specific mutation present, which can be helpful for determining the severity of the condition and guiding treatment options. |